Whether this increase in expression is a consequence of ROS production derived from CIP treatment remains to be determined, as well as the physiological role of SOD in response to CIP, if the mechanism is independent of ROS production. The gene discussed is SOD1; the disease is hereditary sensory and autonomic neuropathy.